WO2008129517A3 - A stabilized delayed release pharmaceutical composition of rabeprazole - Google Patents

A stabilized delayed release pharmaceutical composition of rabeprazole Download PDF

Info

Publication number
WO2008129517A3
WO2008129517A3 PCT/IB2008/051568 IB2008051568W WO2008129517A3 WO 2008129517 A3 WO2008129517 A3 WO 2008129517A3 IB 2008051568 W IB2008051568 W IB 2008051568W WO 2008129517 A3 WO2008129517 A3 WO 2008129517A3
Authority
WO
WIPO (PCT)
Prior art keywords
rabeprazole
stabilized
pharmaceutical composition
delayed release
release pharmaceutical
Prior art date
Application number
PCT/IB2008/051568
Other languages
French (fr)
Other versions
WO2008129517A2 (en
Inventor
Chayapathy Issa
Puneet Mangat
Rajesh Gandhi
Romi Barat Singh
Rajeev Shanker Mathur
Original Assignee
Ranbaxy Lab Ltd
Chayapathy Issa
Puneet Mangat
Rajesh Gandhi
Romi Barat Singh
Rajeev Shanker Mathur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd, Chayapathy Issa, Puneet Mangat, Rajesh Gandhi, Romi Barat Singh, Rajeev Shanker Mathur filed Critical Ranbaxy Lab Ltd
Publication of WO2008129517A2 publication Critical patent/WO2008129517A2/en
Publication of WO2008129517A3 publication Critical patent/WO2008129517A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

The invention relates to a stabilized delayed release pharmaceutical composition of rabeprazole comprising: a. a tablet core comprising rabeprazole or pharmaceutically acceptable salt thereof, sodium carbonate and a. disintegrant selected from the group consisting of crospovidone and low substituted hydroxypropylcelullose; b. a seal coating comprising ethyl cellulose and a disintegrant selected from the group consisting of crospovidone and low substituted hydroxypropylcelullose; and c. an enteric coating.
PCT/IB2008/051568 2007-04-23 2008-04-24 A stabilized delayed release pharmaceutical composition of rabeprazole WO2008129517A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN892DE2007 2007-04-23
IN892/DEL/2007 2007-04-23
IN2046DE2007 2007-09-27
IN2046/DEL/2007 2007-09-27

Publications (2)

Publication Number Publication Date
WO2008129517A2 WO2008129517A2 (en) 2008-10-30
WO2008129517A3 true WO2008129517A3 (en) 2009-05-07

Family

ID=39651210

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2008/051568 WO2008129517A2 (en) 2007-04-23 2008-04-24 A stabilized delayed release pharmaceutical composition of rabeprazole

Country Status (1)

Country Link
WO (1) WO2008129517A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2379226B1 (en) 2008-12-31 2016-04-20 3M Innovative Properties Company Live bioload detection using microparticles
EP2379697A2 (en) 2008-12-31 2011-10-26 3M Innovative Properties Company Sampling devices and methods for concentrating microorganisms
US9284593B2 (en) 2009-12-30 2016-03-15 3M Innovative Properties Company Live bioload detection using microparticles
WO2011082258A2 (en) 2009-12-30 2011-07-07 Regents Of The University Of Minnesota Bone cement and method
GB201003731D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Immediate/delayed drug delivery
GB201003766D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Pulsatile drug release
GB201003734D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Delayed prolonged drug delivery
CN103784414B (en) * 2013-12-18 2018-01-30 北京华禧联合科技发展有限公司 A kind of esomeprazole enteric coatel tablets and preparation method thereof
CN105287425A (en) * 2015-10-29 2016-02-03 沈阳药大制剂新技术有限公司 Stable rabeprazole sodium enteric-coated tablets and preparation method
CN105640915A (en) * 2016-03-02 2016-06-08 吉林修正药业新药开发有限公司 Rebeprazole sodium enteric-coated tablet and preparation process thereof
CN111281855B (en) * 2020-03-23 2021-09-24 乐普制药科技有限公司 Rabeprazole enteric-coated tablet and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004305A1 (en) * 1998-04-20 2000-05-31 Eisai Co., Ltd. Stabilized compositions containing benzimidazole-type compounds
EP1222922A1 (en) * 1999-10-20 2002-07-17 Eisai Co., Ltd. Method for stabilizing benzimidazole compounds
US20040146558A1 (en) * 2003-01-28 2004-07-29 Kyowa Pharmaceutical Co., Ltd. Oral enteric-coated preparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004305A1 (en) * 1998-04-20 2000-05-31 Eisai Co., Ltd. Stabilized compositions containing benzimidazole-type compounds
EP1222922A1 (en) * 1999-10-20 2002-07-17 Eisai Co., Ltd. Method for stabilizing benzimidazole compounds
US20040146558A1 (en) * 2003-01-28 2004-07-29 Kyowa Pharmaceutical Co., Ltd. Oral enteric-coated preparation

Also Published As

Publication number Publication date
WO2008129517A2 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
WO2008129517A3 (en) A stabilized delayed release pharmaceutical composition of rabeprazole
WO2006011159A3 (en) Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability
WO2009066326A3 (en) Improved process for the preparation of prasugrel and its pharmaceutically acceptable salts
WO2007139886A3 (en) Duloxetine hydrochloride delayed release formulations
WO2009085990A3 (en) Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof
WO2004062577A3 (en) Two or more enteric materials to regulate drug release
WO2009066315A3 (en) Sustained release compositions of trimetazidine and process for preparation thereof
WO2008020286A3 (en) Pharmaceutical compositions of duloxetine
WO2011002857A3 (en) 3-cyanoquinoline tablet formulations and uses thereof
WO2010070449A3 (en) Highly pure laquinimod or a pharmaceutically acceptable salt thereof
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2010049449A3 (en) Novel salts of sunitinib
WO2010046932A3 (en) Extended release pharmaceutical composition of minocycline and process thereof
WO2010006904A3 (en) Crystalline forms of rabeprazole sodium
WO2008049922A3 (en) A new process for the preparation of montelukast
WO2008081268A3 (en) Pharmaceutical compositions of entacapone
WO2007110753A3 (en) Extended release dosage forms of metoprolol
WO2010144339A3 (en) A thrombin receptor antagonist and clopidogrel fixed dose tablet
WO2009125975A3 (en) Combination of mitiglinide and metformin and process for preparing same
WO2010137040A3 (en) Novel pharmaceutical compositions of ranolazine
WO2007099555A3 (en) Pharmaceutical tablet compositions containing irbesartan
WO2010018175A3 (en) Oral pharmaceutical formulation for omeprazole comprising a specific separation layer
WO2008039894A3 (en) Atorvastatin pharmaceutical compositions
WO2011064797A3 (en) Controlled release pharmaceutical compositions of galantamine
WO2009150238A3 (en) Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08737972

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08737972

Country of ref document: EP

Kind code of ref document: A2